Global Circulating Tumor Cells Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI01241249

Publication Date:

January 4, 2024

Pages:

131

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Circulating Tumor Cells market size was valued at US$ 1550.1 million in 2023. With growing demand in downstream market, the Circulating Tumor Cells is forecast to a readjusted size of US$ 5942.1 million by 2030 with a CAGR of 21.2% during review period.
The research report highlights the growth potential of the global Circulating Tumor Cells market. Circulating Tumor Cells are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Circulating Tumor Cells. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Circulating Tumor Cells market.
Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of these markers in monitoring disease progression and potentially guiding personalized cancer therapy.
Global Circulating Tumor Cells main players are Menarini-Silicon Biosystems, Qiagen锛圓dnagen锛�, Clearbridge Biomedics, Celsee, Fluidigm. Global top five manufacturers hold a share over 30%.
Key Features:
The report on Circulating Tumor Cells market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Circulating Tumor Cells market. It may include historical data, market segmentation by Type (e.g., CTC Enrichment, CTC Detection), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Circulating Tumor Cells market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Circulating Tumor Cells market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Circulating Tumor Cells industry. This include advancements in Circulating Tumor Cells technology, Circulating Tumor Cells new entrants, Circulating Tumor Cells new investment, and other innovations that are shaping the future of Circulating Tumor Cells.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Circulating Tumor Cells market. It includes factors influencing customer ' purchasing decisions, preferences for Circulating Tumor Cells product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Circulating Tumor Cells market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Circulating Tumor Cells market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Circulating Tumor Cells market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Circulating Tumor Cells industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Circulating Tumor Cells market.
Market Segmentation:
Circulating Tumor Cells market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
CTC Enrichment
CTC Detection
CTC Analysis
Segmentation by application
Breast Cancer
Prostate Cancer
Colorectal Cancer
Lung Cancer
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Menarini-Silicon Biosystems
Qiagen (Adnagen)
Advanced Cell Diagnostics
ApoCell
Epic Sciences
Greiner Bio-one GmbH
Cynvenio
SurExamBio-Tech
Fluxion Biosciences
Ikonisys
Hangzhou Watson Biotech
Biocept
CytoTrack
Guangzhou Wondfo Biotech
Celsee
Clearbridge Biomedics
ANGLE plc

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Circulating Tumor Cells Market Size 2019-2030
2.1.2 Circulating Tumor Cells Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Circulating Tumor Cells Segment by Type
2.2.1 CTC Enrichment
2.2.2 CTC Detection
2.2.3 CTC Analysis
2.3 Circulating Tumor Cells Market Size by Type
2.3.1 Circulating Tumor Cells Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Circulating Tumor Cells Market Size Market Share by Type (2019-2024)
2.4 Circulating Tumor Cells Segment by Application
2.4.1 Breast Cancer
2.4.2 Prostate Cancer
2.4.3 Colorectal Cancer
2.4.4 Lung Cancer
2.4.5 Others
2.5 Circulating Tumor Cells Market Size by Application
2.5.1 Circulating Tumor Cells Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Circulating Tumor Cells Market Size Market Share by Application (2019-2024)
3 Circulating Tumor Cells Market Size by Player
3.1 Circulating Tumor Cells Market Size Market Share by Players
3.1.1 Global Circulating Tumor Cells Revenue by Players (2019-2024)
3.1.2 Global Circulating Tumor Cells Revenue Market Share by Players (2019-2024)
3.2 Global Circulating Tumor Cells Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Circulating Tumor Cells by Regions
4.1 Circulating Tumor Cells Market Size by Regions (2019-2024)
4.2 Americas Circulating Tumor Cells Market Size Growth (2019-2024)
4.3 APAC Circulating Tumor Cells Market Size Growth (2019-2024)
4.4 Europe Circulating Tumor Cells Market Size Growth (2019-2024)
4.5 Middle East & Africa Circulating Tumor Cells Market Size Growth (2019-2024)
5 Americas
5.1 Americas Circulating Tumor Cells Market Size by Country (2019-2024)
5.2 Americas Circulating Tumor Cells Market Size by Type (2019-2024)
5.3 Americas Circulating Tumor Cells Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Circulating Tumor Cells Market Size by Region (2019-2024)
6.2 APAC Circulating Tumor Cells Market Size by Type (2019-2024)
6.3 APAC Circulating Tumor Cells Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Circulating Tumor Cells by Country (2019-2024)
7.2 Europe Circulating Tumor Cells Market Size by Type (2019-2024)
7.3 Europe Circulating Tumor Cells Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Circulating Tumor Cells by Region (2019-2024)
8.2 Middle East & Africa Circulating Tumor Cells Market Size by Type (2019-2024)
8.3 Middle East & Africa Circulating Tumor Cells Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Circulating Tumor Cells Market Forecast
10.1 Global Circulating Tumor Cells Forecast by Regions (2025-2030)
10.1.1 Global Circulating Tumor Cells Forecast by Regions (2025-2030)
10.1.2 Americas Circulating Tumor Cells Forecast
10.1.3 APAC Circulating Tumor Cells Forecast
10.1.4 Europe Circulating Tumor Cells Forecast
10.1.5 Middle East & Africa Circulating Tumor Cells Forecast
10.2 Americas Circulating Tumor Cells Forecast by Country (2025-2030)
10.2.1 United States Circulating Tumor Cells Market Forecast
10.2.2 Canada Circulating Tumor Cells Market Forecast
10.2.3 Mexico Circulating Tumor Cells Market Forecast
10.2.4 Brazil Circulating Tumor Cells Market Forecast
10.3 APAC Circulating Tumor Cells Forecast by Region (2025-2030)
10.3.1 China Circulating Tumor Cells Market Forecast
10.3.2 Japan Circulating Tumor Cells Market Forecast
10.3.3 Korea Circulating Tumor Cells Market Forecast
10.3.4 Southeast Asia Circulating Tumor Cells Market Forecast
10.3.5 India Circulating Tumor Cells Market Forecast
10.3.6 Australia Circulating Tumor Cells Market Forecast
10.4 Europe Circulating Tumor Cells Forecast by Country (2025-2030)
10.4.1 Germany Circulating Tumor Cells Market Forecast
10.4.2 France Circulating Tumor Cells Market Forecast
10.4.3 UK Circulating Tumor Cells Market Forecast
10.4.4 Italy Circulating Tumor Cells Market Forecast
10.4.5 Russia Circulating Tumor Cells Market Forecast
10.5 Middle East & Africa Circulating Tumor Cells Forecast by Region (2025-2030)
10.5.1 Egypt Circulating Tumor Cells Market Forecast
10.5.2 South Africa Circulating Tumor Cells Market Forecast
10.5.3 Israel Circulating Tumor Cells Market Forecast
10.5.4 Turkey Circulating Tumor Cells Market Forecast
10.5.5 GCC Countries Circulating Tumor Cells Market Forecast
10.6 Global Circulating Tumor Cells Forecast by Type (2025-2030)
10.7 Global Circulating Tumor Cells Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 Menarini-Silicon Biosystems
11.1.1 Menarini-Silicon Biosystems Company Information
11.1.2 Menarini-Silicon Biosystems Circulating Tumor Cells Product Offered
11.1.3 Menarini-Silicon Biosystems Circulating Tumor Cells Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Menarini-Silicon Biosystems Main Business Overview
11.1.5 Menarini-Silicon Biosystems Latest Developments
11.2 Qiagen (Adnagen)
11.2.1 Qiagen (Adnagen) Company Information
11.2.2 Qiagen (Adnagen) Circulating Tumor Cells Product Offered
11.2.3 Qiagen (Adnagen) Circulating Tumor Cells Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Qiagen (Adnagen) Main Business Overview
11.2.5 Qiagen (Adnagen) Latest Developments
11.3 Advanced Cell Diagnostics
11.3.1 Advanced Cell Diagnostics Company Information
11.3.2 Advanced Cell Diagnostics Circulating Tumor Cells Product Offered
11.3.3 Advanced Cell Diagnostics Circulating Tumor Cells Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Advanced Cell Diagnostics Main Business Overview
11.3.5 Advanced Cell Diagnostics Latest Developments
11.4 ApoCell
11.4.1 ApoCell Company Information
11.4.2 ApoCell Circulating Tumor Cells Product Offered
11.4.3 ApoCell Circulating Tumor Cells Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 ApoCell Main Business Overview
11.4.5 ApoCell Latest Developments
11.5 Epic Sciences
11.5.1 Epic Sciences Company Information
11.5.2 Epic Sciences Circulating Tumor Cells Product Offered
11.5.3 Epic Sciences Circulating Tumor Cells Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Epic Sciences Main Business Overview
11.5.5 Epic Sciences Latest Developments
11.6 Greiner Bio-one GmbH
11.6.1 Greiner Bio-one GmbH Company Information
11.6.2 Greiner Bio-one GmbH Circulating Tumor Cells Product Offered
11.6.3 Greiner Bio-one GmbH Circulating Tumor Cells Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Greiner Bio-one GmbH Main Business Overview
11.6.5 Greiner Bio-one GmbH Latest Developments
11.7 Cynvenio
11.7.1 Cynvenio Company Information
11.7.2 Cynvenio Circulating Tumor Cells Product Offered
11.7.3 Cynvenio Circulating Tumor Cells Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Cynvenio Main Business Overview
11.7.5 Cynvenio Latest Developments
11.8 SurExamBio-Tech
11.8.1 SurExamBio-Tech Company Information
11.8.2 SurExamBio-Tech Circulating Tumor Cells Product Offered
11.8.3 SurExamBio-Tech Circulating Tumor Cells Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 SurExamBio-Tech Main Business Overview
11.8.5 SurExamBio-Tech Latest Developments
11.9 Fluxion Biosciences
11.9.1 Fluxion Biosciences Company Information
11.9.2 Fluxion Biosciences Circulating Tumor Cells Product Offered
11.9.3 Fluxion Biosciences Circulating Tumor Cells Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Fluxion Biosciences Main Business Overview
11.9.5 Fluxion Biosciences Latest Developments
11.10 Ikonisys
11.10.1 Ikonisys Company Information
11.10.2 Ikonisys Circulating Tumor Cells Product Offered
11.10.3 Ikonisys Circulating Tumor Cells Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Ikonisys Main Business Overview
11.10.5 Ikonisys Latest Developments
11.11 Hangzhou Watson Biotech
11.11.1 Hangzhou Watson Biotech Company Information
11.11.2 Hangzhou Watson Biotech Circulating Tumor Cells Product Offered
11.11.3 Hangzhou Watson Biotech Circulating Tumor Cells Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Hangzhou Watson Biotech Main Business Overview
11.11.5 Hangzhou Watson Biotech Latest Developments
11.12 Biocept
11.12.1 Biocept Company Information
11.12.2 Biocept Circulating Tumor Cells Product Offered
11.12.3 Biocept Circulating Tumor Cells Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Biocept Main Business Overview
11.12.5 Biocept Latest Developments
11.13 CytoTrack
11.13.1 CytoTrack Company Information
11.13.2 CytoTrack Circulating Tumor Cells Product Offered
11.13.3 CytoTrack Circulating Tumor Cells Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 CytoTrack Main Business Overview
11.13.5 CytoTrack Latest Developments
11.14 Guangzhou Wondfo Biotech
11.14.1 Guangzhou Wondfo Biotech Company Information
11.14.2 Guangzhou Wondfo Biotech Circulating Tumor Cells Product Offered
11.14.3 Guangzhou Wondfo Biotech Circulating Tumor Cells Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Guangzhou Wondfo Biotech Main Business Overview
11.14.5 Guangzhou Wondfo Biotech Latest Developments
11.15 Celsee
11.15.1 Celsee Company Information
11.15.2 Celsee Circulating Tumor Cells Product Offered
11.15.3 Celsee Circulating Tumor Cells Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Celsee Main Business Overview
11.15.5 Celsee Latest Developments
11.16 Clearbridge Biomedics
11.16.1 Clearbridge Biomedics Company Information
11.16.2 Clearbridge Biomedics Circulating Tumor Cells Product Offered
11.16.3 Clearbridge Biomedics Circulating Tumor Cells Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Clearbridge Biomedics Main Business Overview
11.16.5 Clearbridge Biomedics Latest Developments
11.17 ANGLE plc
11.17.1 ANGLE plc Company Information
11.17.2 ANGLE plc Circulating Tumor Cells Product Offered
11.17.3 ANGLE plc Circulating Tumor Cells Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 ANGLE plc Main Business Overview
11.17.5 ANGLE plc Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂